IDiyas

For the Inventor, By the Inventor

Lohmar, Germany

Franz-Josef Van Der Staay

USPTO Granted Patents = 10

Average Co-Inventor Count = 10.7

ph-index = 7

Forward Citations = 117(Granted Patents)


Location History:

  • Lohmar/Wahlscheid, DE (1998 - 2001)
  • Lohmar-Wahlscheid, DE (2002)
  • Lohmar, DE (2003 - 2006)

Company Filing History:

goldMedal10 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1998-2006

Loading Chart...
10 patents (USPTO):Explore Patents
1. 6998402 - Substituted imidazotriazinones (2006-02-14),
2. 6589949 - 3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases (2003-07-08),
3. 6573263 - Substituted imidazotriazinones (2003-06-03),
4. 6344471 - 2-aminocarbonyl-5(2H)-isoxazolones as ligands of a DFP-binding site treatment of CNS-diseases (2002-02-05),
5. 6174897 - Bis-(quinolyl)-diamines (2001-01-16),
6. 5874438 - 2,2'-bridged bis-2,4-diaminoquinazolines (1999-02-23),
7. 5866562 - Ring-bridged bis-quinolines (1999-02-02),
8. 5760230 - 4, 4'-bridged bis-2, 4-diaminoquinazolines (1998-06-02),
9. 5756517 - Use of bisquinoline compounds in the treatment of cerebral disorders (1998-05-26),
10. 5739127 - 2,4'-bridged bis-2,4-diaminoquinazolines (1998-04-14),

Title: **Franz-Josef Van Der Staay: Innovator in Medicinal Chemistry**

Introduction

Franz-Josef Van Der Staay, located in Lohmar, Germany, is a prominent inventor known for his substantial contributions to medicinal chemistry. With a remarkable portfolio of 10 patents, his work primarily focuses on compounds that enhance cognitive functions and combat central nervous system diseases.

Latest Patents

Among his latest innovations are the "Substituted imidazotriazinones," which are novel compounds designed to improve perception, concentration, learning capacity, and memory retentiveness. His other significant invention is the "3-oxo-2,1-benzisoxazol-1(3H)-carboxamides" targeting treatments for CNS diseases. This invention includes a range of specialized compounds that have shown potential in addressing cognitive disorders, including Alzheimer's and other forms of dementia.

Career Highlights

Franz-Josef Van Der Staay is affiliated with Bayer Aktiengesellschaft, a leading multinational corporation focusing on life sciences. His innovative approach and dedication to research have led to groundbreaking developments in the pharmaceutical industry.

Collaborations

Throughout his career, Van Der Staay has collaborated with notable professionals in the field, including Joachim Schuhmacher and Bernard Schmidt. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Franz-Josef Van Der Staay stands out as a visionary inventor whose work continues to influence the medical field. His numerous patents reflect a commitment to advancing science and improving human health through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…